Sponsor or institution
Clinical trials and research at Henan Genuine Biotech Co., Ltd.
As of November 12, 2026, Find a Trial lists 5 clinical trials run by Henan Genuine Biotech Co., Ltd. that are recruiting, in China. By phase: Phase 1 (2), Phase 1/2 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| GEN-725 plus Dositinib for EGFR-mutant non-small cell lung cancer | Phase 1/2 | Beijing and 4 other locations | Recruiting | Jan 23, 2026 |
| Single-dose CL-197 capsules for adults with HIV-1 infection | Phase 2 | Beijing | Recruiting | Dec 30, 2025 |
| Dositinib dose-escalation and expansion for advanced EGFR‑mutant non-small cell lung cancer | Phase 1/2 | Beijing and 4 other locations | Recruiting | Nov 17, 2025 |
| GEN-725 tablets for adults with advanced solid tumors | Phase 1 | Harbin and 3 other locations | Recruiting | Nov 17, 2025 |
| Single 3 mg Azvudine safety and blood-level test for adults with mild-to-moderate kidney decline and healthy adults | Phase 1 | Beijing, Beijing Municipality | Recruiting | Jun 3, 2025 |
All recruiting trials (5)
-
GEN-725 plus Dositinib for EGFR-mutant non-small cell lung cancer
This study will test whether taking GEN-725 together with Dositinib is safe and may help adults with advanced EGFR-mutant non-small cell lung cancer.
-
Single-dose CL-197 capsules for adults with HIV-1 infection
This trial will test if a single dose of CL-197 capsules is safe and lowers HIV-1 levels in adults who have never taken HIV medications.
-
Dositinib dose-escalation and expansion for advanced EGFR‑mutant non-small cell lung cancer
This trial tests whether the EGFR inhibitor dositinib is safe and active for adults with locally advanced or metastatic non‑small cell lung cancer that has EGFR mutations.
-
GEN-725 tablets for adults with advanced solid tumors
This phase 1 study will test whether GEN-725 tablets are safe, how the body handles them, and whether they might help adults whose advanced solid tumors have not responded to standard treatments.
-
Single 3 mg Azvudine safety and blood-level test for adults with mild-to-moderate kidney decline and healthy adults
This trial gives a single 3 mg dose of Azvudine to adults with mild-to-moderate kidney function decline and to healthy adults to test how the body handles the drug and whether it is safe.
Quick answers
How many clinical trials run by Henan Genuine Biotech Co., Ltd. are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 1/2: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.